Literature DB >> 35057699

Novel RCBTB1 variants causing later-onset non-syndromic retinal dystrophy with macular chorioretinal atrophy.

Andrew J Catomeris1,2, Brian G Ballios2,3, Riccardo Sangermano2, Naomi E Wagner2, Jason I Comander2, Eric A Pierce2, Emily M Place2, Kinga M Bujakowska2, Rachel M Huckfeldt2.   

Abstract

BACKGROUND: Variants in RCBTB1 were recently described to cause a retinal dystrophy with only eight families described to date and a predominant phenotype of macular atrophy and peripheral reticular degeneration. Here, we further evaluate the genotypic and phenotypic characteristics of biallelic RCBTB1-associated retinal dystrophy in a North American clinic population.
METHODS: A retrospective analysis of genetic and clinical features was performed in individuals with biallelic variants in RCBTB1.
RESULTS: Three unrelated individuals of French-Canadian descent with rare biallelic RCBTB1 variants were identified. All individuals shared a novel p.(Ser342Leu) missense variant; one patient was homozygous whereas the other two each possessed a second unique novel variant p.(Gln120*) and p.(Pro224Leu). All three had macula-predominant disease with symptom onset in the fifth decade of life.
CONCLUSION: This report adds to the genetic diversity of RCBTB1-associated disease. These cases confirm the later-onset, relative to many other retinal dystrophies, and macular focus of disease described in most cases to-date. They are thus a reminder of considering hereditary disease in the differential for later-onset macular atrophy.

Entities:  

Keywords:  Macular atrophy; RCBTB1; retinal dystrophy

Mesh:

Substances:

Year:  2022        PMID: 35057699      PMCID: PMC9177531          DOI: 10.1080/13816810.2021.2023196

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.274


  34 in total

Review 1.  The molecular basis of human retinal and vitreoretinal diseases.

Authors:  Wolfgang Berger; Barbara Kloeckener-Gruissem; John Neidhardt
Journal:  Prog Retin Eye Res       Date:  2010-03-31       Impact factor: 21.198

2.  Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations.

Authors:  Zhiqin Huang; Dan Zhang; Shang-Chih Chen; Jennifer A Thompson; Terri McLaren; Tina Lamey; John N De Roach; Samuel McLenachan; Fred K Chen
Journal:  Stem Cell Res       Date:  2019-08-23       Impact factor: 2.020

3.  Predicting functional effect of human missense mutations using PolyPhen-2.

Authors:  Ivan Adzhubei; Daniel M Jordan; Shamil R Sunyaev
Journal:  Curr Protoc Hum Genet       Date:  2013-01

4.  Phenotypic findings in C1QTNF5 retinopathy (late-onset retinal degeneration).

Authors:  Vasileios Soumplis; Panagiotis I Sergouniotis; Anthony G Robson; Michel Michaelides; Anthony T Moore; Graham E Holder; Andrew R Webster
Journal:  Acta Ophthalmol       Date:  2013-01-07       Impact factor: 3.761

5.  Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.

Authors:  Vidyullatha Vasireddy; Monica M Jablonski; Naheed W Khan; Xiao Fei Wang; Priya Sahu; Janet R Sparrow; Radha Ayyagari
Journal:  Exp Eye Res       Date:  2009-08-13       Impact factor: 3.467

6.  Deep clinical phenotyping and gene expression analysis in a patient with RCBTB1-associated retinopathy.

Authors:  Zhiqin Huang; Dan Zhang; Jennifer A Thompson; Saumya S Jamuar; Danial Roshandel; Luke Jennings; Carla Mellough; Jason Charng; Shang-Chih Chen; Terri L McLaren; Tina M Lamey; Enid Chelva; John N De Roach; Choi Mun Chan; Samuel McLenachan; Fred K Chen
Journal:  Ophthalmic Genet       Date:  2021-02-24       Impact factor: 1.803

7.  The ubiquitin-conjugating enzyme UBE2E3 and its import receptor importin-11 regulate the localization and activity of the antioxidant transcription factor NRF2.

Authors:  Kendra S Plafker; Scott M Plafker
Journal:  Mol Biol Cell       Date:  2014-11-05       Impact factor: 4.138

8.  Isolated and Syndromic Retinal Dystrophy Caused by Biallelic Mutations in RCBTB1, a Gene Implicated in Ubiquitination.

Authors:  Frauke Coppieters; Giulia Ascari; Katharina Dannhausen; Konstantinos Nikopoulos; Frank Peelman; Marcus Karlstetter; Mingchu Xu; Cécile Brachet; Isabelle Meunier; Miltiadis K Tsilimbaris; Chrysanthi Tsika; Styliani V Blazaki; Sarah Vergult; Pietro Farinelli; Thalia Van Laethem; Miriam Bauwens; Marieke De Bruyne; Rui Chen; Thomas Langmann; Ruifang Sui; Françoise Meire; Carlo Rivolta; Christian P Hamel; Bart P Leroy; Elfride De Baere
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

9.  Gene replacement therapy restores RCBTB1 expression and cilium length in patient-derived retinal pigment epithelium.

Authors:  Zhiqin Huang; Dan Zhang; Shang-Chih Chen; Luke Jennings; Livia S Carvalho; Sue Fletcher; Fred K Chen; Samuel McLenachan
Journal:  J Cell Mol Med       Date:  2021-10-07       Impact factor: 5.310

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.